Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was down 12.4% on Monday . The stock traded as low as GBX 1.53 ($0.02) and last traded at GBX 1.53 ($0.02). Approximately 1,131,357 shares were traded during mid-day trading, a decline of 4% from the average daily volume of 1,177,392 shares. The stock had previously closed at GBX 1.75 ($0.02).
Cizzle Biotechnology Stock Performance
The firm has a market capitalization of £6.50 million, a PE ratio of -164.00 and a beta of 0.38. The stock’s 50-day simple moving average is GBX 1.91 and its 200-day simple moving average is GBX 1.85.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Industrial Chemicals: 3 Stocks Poised for Growth in the New Year
- What is the S&P 500 and How It is Distinct from Other Indexes
- Rising Freight Rates: The Carrier’s Comeback in a Shifting Market
- What is the NASDAQ Stock Exchange?
- Why Value Stocks Are the Best Bet Today—and Goldman Sachs Agrees
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
